OHRSTROM JAN K 4
4 · AVIGEN INC \DE · Filed Dec 21, 2009
Insider Transaction Report
Form 4
AVIGEN INC \DEAVGN
OHRSTROM JAN K
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−6,667→ 0 totalExercise: $6.73Exp: 2017-05-30→ Common Stock $0.001 par value (6,667 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−20,000→ 0 totalExercise: $2.96Exp: 2018-05-19→ Common Stock $0.001 par value (20,000 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2009-12-18−30,000→ 0 totalExercise: $6.04Exp: 2017-02-05→ Common Stock $0.001 par value (30,000 underlying)
Footnotes (3)
- [F1]This option, which provided for vesting in three annual installments of 9,900 shares, 10,200 shares and 9,900 shares on February 5, 2008, 2009, and 2010, respectively, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.
- [F2]This option, which provided for vesting in three annual installments of 2,200 shares, 2,266 shares and 2,201 shares on May 30, 2008, 2009, and 2010, respectively, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.
- [F3]This option, which provided for vesting in three annual installments of 6,600 shares, 6,800 shares and 6,600 shares on May 19, 2009, 2010, and 2011, respectively, was cancelled pursuant to the terms of the Agreement and Plan of Merger by and among Avigen, Inc., MediciNova, Inc., and Absolute Merger, Inc., a wholly owned subsidiary of MediciNova, Inc.